The results demonstrate that CNN-based methods trained on a relatively small database of CT scans can detect the cranial and caudal limits of breast CTVs with an accuracy comparable to that of an atlas-based segmentation. Besides the accuracy level, a CNN-based method might be a better option than atlas-based segmentation for this application because it requires less manual effort for setup. In the future, methods 2 and 3 will be evaluated in larger datasets to observe how the accuracy and computation scale. Additionally, breast limits on other imaging planes will be considered. 
Purpose or Objective
The use of imaging has a crucial role in radiotherapy (RT), for localizing both tumours and organs at risk (OARs). Imaging is also an integral part of treatment planning, dose calculations and patient set-up. Magnetic resonance (MR) imaging provides excellent soft tissue contrast. A major argument for replacing CT with MR in the RT process (MRI-only technique) is the significantly improved spatial definition of the target and OARs. In addition, an MRI-only RT workflow may eliminate image registration uncertainties between MR and CT. Excluding CT will simplify the patient logistics process, reduce the number of appointments and may also decrease the workload and reduce costs. The purpose of the MR-PROTECT (The MRonly Prostate RadiOTherapy Excluding CT) trial was to implement and prospectively study an MRI-only RT workflow for prostate cancer.
Material and Methods
Preceding the clinical study and on different patient cohorts, the following tasks were performed: We validated and used the MRiPlanner (Spectronic Medical AB, Sweden) to generate syntheticCT (sCT) from T2w MR-sequence. Target delineation directly on the T2w image was compared to the traditional combined MR/CT delineation process. A dedicated gold fiducial detection tool for MR workflow was developed and tested. A QA method for using cone beam CT (CBCT) for quality control of the sCT was validated. For the clinical implementation study, forty patients with localized prostate cancer were included for treatment according to an MRI-only workflow based on the validated methods. A CT was acquired after the MR examination, but only strictly used in the background for evaluation of the implementation process. Results For the tasks preceding the clinical study, the following results were obtained: The validation study of the sCT confirmed that MRiPlanner can be used clinically with negligible differences between sCT and CT dose distributions for target and relevant organs at risk. The CTV using MRI-only for delineation was consistently smaller (18%) than using CTV for a combined CT/MR workflow. A dedicated multiecho gradient echo sequence was shown to be a feasible and reliable way for manual identification of fiducial markers (100%). CBCT was a clinically feasible QA procedure for MRI-only RT of prostate cancer patients. Thereby all the methods developed for the clinical study was working appropriately. In the clinical study, 39 of 40 patients completed their treatment with no major deviations. One patient was too large for the field of view of the MRscanner.
Conclusion
The results of this prospective clinical trial demonstrate that a successful MRI-only implementation can be achieved with a fine detailed work plan and thoroughly validated methods. One patient was excluded due to a large body contour, a problem that has been solved in a later process during our work. Our results confirm that the CT can successfully be entirely excluded. MRI-only RT enables a high precision RT technique with simplified logistics and less workload. 
Purpose or Objective
Lung cancer patients undergoing stereotactic ablative body radiotherapy receive 4DCT for treatment planning. Often, an internal gross target volume (iGTV) is directly delineated without defining a GTV. However, the GTV volume and shape are important parameters for prognostic and dose modelling. In this study, we demonstrate and validate a new method to automatically generate the GTV, on any phase, directly from the iGTV.
Material and Methods
Eleven 4DCT data-sets and delineations were collected from an institutional archive; each plan had a contoured iGTV. The method assumes deformation of the GTV is small compared to its motion. Rigid registration was therefore performed to map the tumour across all 4D phases to a reference phase, e.g. 50%. Registration performance was assessed by the mean and standard deviation (SD) of the correlation ratio cost function. Figure 1 demonstrates the GTV generation method. The iGTV should encompass the GTV volume at all positions across the respiratory cycle (A). Therefore, inversely, if the iGTV is translated by the registration displacements of each phase to the reference (B), the intersection of all translated iGTVs will recreate a GTV volume in the reference coordinate frame, GTVgen (C).
For validation, a radiation oncologist contoured the GTV on the 50% phase (GTV50). For comparison, surface distance to agreement (DTA) was calculated by extracting the absolute perpendicular distance from the surface of GTVgen to GTV50, with mean and SD recorded. For geometric comparison, the volume (V) and surface area (A) were extracted and ratios calculated. For shape, the ratio of sphericity, S=(π^(1/3)(6V)^(2/3))/A, was calculated. To assess position, the vector distance between centre of mass (COM) was extracted. Results Mean registration cost function was 0.95. The mean tumour motion amplitude calculated as vector of three directions was 7.47mm (range: 2.75-12.60mm). All tumours analysed were T-stage 1 or 2. Six patients had an upper lobe tumour and five had a lower lobe tumour. Observer variation is reported as 1.2-1.8mm SD (Peulen et al., 2015) . The distance variability, DTA SD, is within the range of observer variation ( Fig. 2A) . Pictorial examples (Fig. 2B ) display good agreement. GTV shape was highly accurate. GTV volume was well estimated and a ratio change represents small volume difference.
Patient 5 displayed worst results, with a 3.5mm COM deviation and largest sphericity ratio, however, the segmented volume is accurate. Patient 7 provides an example of higher DTA SD but this seems to be driven by observer disagreement, rather than issues with algorithm performance.
Conclusion
This study presents and validates a method for automatically generating the GTV from an iGTV. The technique provides a representation of the GTV that is accurate within observer variation. This method supports calculating delivered dose to the GTV without additional delineation and will facilitate large-scale retrospective analysis of patients treated in the routine setting.
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